Not exact matches
Common adverse events (AEs) associated with inotuzumab ozogamicin
include abdominal pain, anemia, fatigue, febrile neutropenia, headache, hemorrhage, hyperbilirubinemia, infection, leukopenia, liver damage, nausea, neutropenia,
pyrexia, and thrombocytopenia.
Commonly experienced adverse events
included thrombocytopenia, leukopenia, neutropenia, anemia, diarrhea, gastroenteritis, bronchitis, nasopharyngitis, upper respiratory tract infection, cough, rash, asthenia, muscle spasm,
pyrexia, and fatigue.
Commonly reported adverse reactions
included infusion reaction, diarrhea, nausea, vomiting, fatigue,
pyrexia, upper respiratory tract infection, muscle spasm, cough, and dyspnea.
If there are signs, they
include anorexia (not eating),
pyrexia (fever) apathy and prostration.
Other conditions
include if your cat is suffering from fever (
pyrexia), is pregnant, is feeding kittens (lactation) or has just had surgery.